A World-Class Leadership Team Building the Future of Precision Oncology
Where scientific excellence meets decades of regulatory, clinical, and commercial execution.
Built by Canada’s Most Experienced Diagnostics and Genomics Leaders
GentraceDx is the result of a rare collaboration between:
- Genetrack Biolabs – a recognized leader in regulated diagnostics, with over 25 years of experience in clinical testing, LDT kit manufacturing and distribution, and secure patient data infrastructure.
- The Michael Smith Genome Sciences Centre (GSC) – one of the world’s leading cancer genomics institutions, responsible for sequencing thousands of cancer patients under CAP/CLIA/DAP frameworks.
- Genome Canada and Genome BC – through the highly competitive GAPP, supporting the scientific development and national implementation of the platform.
Together, this team represents unmatched scientific depth, operational readiness, and national credibility.
Industry Leadership
Dr. June Wong, PhD
Director & CEO
Dr. Supipi Duffy, PhD
Director of Strategic Programs
Clement Ma, BComm, MBA
Chief Commercial & Regulatory Officer (CCRO)
Shogo Ide, BComm
Lead Developer
Scientific Leadership
Dr. Steven Jones, PhD, FRS(C), FCAHS, FRCP(Edin)
Director of Science
Head, Bioinformatics
Distinguished Scientist
Dr. Yussanne Ma, PhD
Director of Operations
Dr. Richard Moore, PhD
Group Leader, Sequencing
Dr. Robin Coope, PhD, PEng
Group Leader, Instrumentation
Dr. Andy Mungall, PhD
Senior Group Leader, Genomics Services
Eric Chuah, B.Sc.
Head, Bioinformatics and Data Science
Karen Mungall, B.Sc.
Senior Group Leader, Bioinformatics
Engineering & AI Leadership
AI & Bioinformatics
GenTraceDx integrates advanced AI and bioinformatics capabilities to support continuous, patient-specific clinical intelligence:
- Longitudinal evidence monitoring
- Variant interpretation engines
- AI-driven reanalysis
- Clinical trial matching
- Multiomic data integration
- Scalable cloud infrastructure
- Regulatory-compliant software engineering
Clinical Advisors
Clinical Oncology Advisory Panel
A growing network of oncologists, surgeon-scientists, and cancer researchers across Canada and the United States who support:
- Clinical interpretation
- Trial integration
- Off-label DIN pathways
- Special Access Program (SAP) mechanisms
- Neoantigen vaccine development
This panel will expand significantly as the national pilot progresses.
Operational Leadership
Operations & Quality Team
GenTraceDx leverages extensive experience in regulated operations and quality systems across Health Canada and U.S. FDA frameworks, including:
- GMP manufacturing
- MDEL oversight
- FDA Class I kit compliance
- Nationwide clinician support
- Sample logistics and turnaround management
- Data privacy & security compliance (PIPEDA, PHIPA, HIPAA-equivalent)
Our Story
Born from a clinical reality. Built to address it.
Genomic testing today is limited in scope and depth, relying on fixed gene panels and producing a single, static report that does not evolve as new therapies, biomarkers, and clinical trials emerge.
Published studies suggest that up to 88% of patients receive no actionable findings, not necessarily because no meaningful information exists, but because current approaches capture only part of the biology and do not update over time.
GenTraceDx is designed to change that.
Supported by Leading Institutions
GenTraceDx is being developed through a national collaboration:
Join Us
Help Build the Future of Precision Oncology
We are building across:
- Bioinformatics
- AI/ML engineering
- Clinical genomics
- Laboratory operations
- Regulatory affairs
- Commercial strategy
- Oncology collaborations